Vietnam, et al UNAIDS Drug Project

9 December 1997

A United Nations Program on HIV/ AIDS (UNAIDS) has been announced toimprove access to costly drugs for the treatment of HIV and AIDS in Vietnam, Uganda, the Ivory Coast and Chile, according to the Vietnam News.

The UNAIDS HIV Drug Access Initiative will be a collaborative effort between the public and private sector in the four countries. It will ensure that the health care services in these countries will be adapted to allow the effective use and distribution of drugs to treat these conditions. International pharmaceutical companies participating in the project will subsidize the prices of drugs, which could lead to the cost of treating HIV and AIDS patients being reduced by as much as 80%.

In Vietnam, two bodies will be established to coordinate the project. One will be a national advisory body under the Ministry of Health, which will bring together health professionals and those suffering from HIV and AIDS. The other group will be a non-profit making company, which will be funded by the participating pharmaceutical companies which will provide drugs at subsidized prices.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight